Fundz

Neuronostics raised £2.1m in seed funding led by Ascension Life Fund to accelerate the development of epilepsy diagnosis technology

PRIVATEApr 08, 2024

Amount Raised

£2.1 Million

Round Type

Seed

BristolBiotechnologyHealth Care

Investors

Empirical VenturesThe Cornwall And Isles Of Scilly Investment FundQant XAscension Life Fund

Description

Neuronostics has raised over £2m funding through a successful round of seed funding, led by the Ascension Life Fund. The funding will allow Neuronostics to accelerate its route to market in the UK and Middle East, while also begin seeking regulatory approval from the FDA for the US market.

Quick answer

Neuronostics raised £2.1 Million in a Seed round, dated April 8, 2024. Investors: Empirical Ventures, The Cornwall And Isles Of Scilly Investment Fund, Qant X and Ascension Life Fund. Neuronostics is based in Bristol, England, United Kingdom.

How much did Neuronostics raise?
Neuronostics raised £2.1 Million in a Seed round on April 8, 2024.
Who invested in Neuronostics?
Empirical Ventures, The Cornwall And Isles Of Scilly Investment Fund, Qant X and Ascension Life Fund are named as investors in this round.
What does Neuronostics do?
At Neuronostics we are reimagining the way neurological conditions are diagnosed, treated, and monitored.
Where is Neuronostics based and how big is it?
Neuronostics is based in Bristol, England, United Kingdom.
Who are the decision-makers at Neuronostics?
Fundz holds 1 contact at Neuronostics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Neuronostics that raised within 45 days of this round, from Fundz verified event records.

  • Bicycle Therapeutics raised $555M (Post-IPO Equity) on May 23, 2024.
  • Grey Wolf Therapeutics raised $50M (Series B) on May 23, 2024.
  • Turn Therapeutics Inc. raised an undisclosed amount on May 23, 2024.
  • Radar Therapeutics raised $13M (Seed) on May 23, 2024.
  • Allez Health raised $60M (Series A) on May 22, 2024.
  • En Carta Diagnostics raised $1.6M (Pre-Seed) on May 22, 2024.

Who to call at Neuronostics, and when

A new round usually means Neuronostics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Neuronostics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Neuronostics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Neuronostics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Neuronostics

Location

Bristol, England, United Kingdom

About

At Neuronostics we are reimagining the way neurological conditions are diagnosed, treated, and monitored. We use the power of mathematical modelling to develop novel biomarkers that create faster paths to diagnosis and effective treatment. Our first clinical indication, BioEP is an entirely new digital biomarker of epilepsy BioEP uses background EEG data and mathematical modelling to predict the likelihood of seizures. Our BioEP risk score supports clinical diagnostic and prognostic decisions of epilepsy. Our vision is that digital biomarkers are used routinely in neurology centres around the world to create a more proactive and anticipatory model of care. This will revolutionise neurological healthcare and radically improve the lives of people at risk of or living with neurological conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neuronostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Neuronostics's next move

See what Strategic adds

Neuronostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.